clinical trials for tirzepatide New Dual Incretin Agonist Type 2 Diabetes Clinical trials show impressive weight-loss

Same-day care starts at $149

semaglutide carries a black-box warning due to animal studies showing thyroid tumors in rodentsthough no human cases have been confirmed in clinical trials

For patients without clear indication for b12 supplementation, using a compounded combination means paying extra for an additive that may provide no benefit

Constipation, diarrhea, indigestion, and gas are other potential side effects of Zepbound all of which can contribute to stomach pain during treatment

Some might complain of changes in memory, focus, logic, and problem-solving skills

The recent conclusion of major phase 3 trials for the oral glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide represents another notable setback in this endeavor (Scragg et al., 2025)